The Association Between SBP and Mortality Risk Differs with Level of Cognitive Function in Very Old Individuals

Overview

Journal J Hypertens

Specialty Cardiology & Vascular Diseases

Date 2016 Mar 4

PMID 26938812

Citations 14

Authors

Bodil Weidung

Hakan Littbrand

Peter Nordstrom

Bo Carlberg

Yngve Gustafson

Affiliations

Soon will be listed here.

Abstract

Objective: Cognitive impairment and dementia are highly prevalent in very old populations. Cardiovascular disease is a common cause of death in people with dementia.This study investigated whether the association of blood pressure (BP) with mortality differed with respect to mini-mental state examination (MMSE) score in a representative sample of very old individuals.

Methods: The sample consisted of 1115 participants aged 85, 90, and at least 95 years from the Umeå85+/GErontological Regional DAtabase cohort study. The main outcome was all-cause mortality within 2 years according to BP and MMSE score, using Cox proportional-hazard regression models adjusted for sociodemographic and clinical characteristics associated with death.

Results: Mean age, MMSE score, and SBP and DBP were 89.4 ± 4.6 years, 21.1 ± 7.6, 146.1 ± 23.4 mmHg, and 74.1 ± 11.7 mmHg, respectively. Within 2 years, 293 (26%) participants died. BP was not associated independently with mortality risk, except among participants with MMSE scores of 0-10 among whom mortality risk was increased in association with SBP at least 165 mmHg and 125 mmHg or less, compared with 126-139 mmHg (adjusted hazard ratio 4.54, 95% confidence interval = 1.52-13.60 and hazard ratio 2.23, 95% confidence interval = 1.12-4.45, respectively). In age and sex-adjusted analyses, SBP 125 mmHg or less was associated with increased mortality risk in participants with MMSE scores at least 18.

Conclusion: In people aged at least 85 years, the association of SBP with mortality appears to differ with respect to MMSE score. Very old individuals with very severe cognitive impairment and low or high BP may have increased mortality risk.

Citing Articles

The impact of modifiable health metrics on mortality for older adults with low cognitive function.

Wang W, Sun P, Lv T, Li M Front Public Health. 2024; 12:1304876.

PMID: 38333737 PMC: 10850326. DOI: 10.3389/fpubh.2024.1304876.

Screening for cognitive impairment in older adults with hypertension: the HYPER-COG study.

Rivasi G, DAndria M, Bulgaresi M, Sgrilli F, Casini G, Falzone D J Hum Hypertens. 2023; 37(11):1000-1006.

PMID: 36932153 DOI: 10.1038/s41371-023-00817-x.

Body mass index and death by cognitive impairment.

Li Z, Gong X, Cui X, Zhang W, Wang Y, Wu D Aging Clin Exp Res. 2023; 35(3):689-698.

PMID: 36795235 DOI: 10.1007/s40520-023-02346-6.

Mortality rate of high cardiovascular risk patients with mild cognitive impairment.

Yaneva-Sirakova T, Traykov L Sci Rep. 2022; 12(1):11961.

PMID: 35831445 PMC: 9279402. DOI: 10.1038/s41598-022-15823-1.

Combined association of cognitive impairment and poor oral health on mortality risk in older adults: Results from the NHANES with 15 years of follow-up.

Li A, Chen Y, Visser A, Marks L, Tjakkes G J Periodontol. 2021; 93(6):888-900.

PMID: 34533839 PMC: 9298999. DOI: 10.1002/JPER.21-0292.

References

Attems J, Konig C, Huber M, Lintner F, Jellinger K . Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. J Alzheimers Dis. 2005; 8(1):57-62. DOI: 10.3233/jad-2005-8107. View

Kalaria R . Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke. 2012; 43(9):2526-34. DOI: 10.1161/STROKEAHA.112.655803. View

Anderson L, McConnell S . Cognitive health: an emerging public health issue. Alzheimers Dement. 2009; 3(2 Suppl):S70-3. DOI: 10.1016/j.jalz.2007.01.018. View

Sabayan B, Oleksik A, Maier A, van Buchem M, Poortvliet R, de Ruijter W . High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012; 60(11):2014-9. DOI: 10.1111/j.1532-5415.2012.04203.x. View

Sabayan B, Jansen S, Oleksik A, van Osch M, van Buchem M, van Vliet P . Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Res Rev. 2012; 11(2):271-7. DOI: 10.1016/j.arr.2011.12.009. View

Nelson L, Gard P, Tabet N . Hypertension and inflammation in Alzheimer's disease: close partners in disease development and progression!. J Alzheimers Dis. 2014; 41(2):331-43. DOI: 10.3233/JAD-140024. View

der Wardt V, Logan P, Conroy S, Harwood R, Gladman J . Antihypertensive treatment in people with dementia. J Am Med Dir Assoc. 2014; 15(9):620-9. DOI: 10.1016/j.jamda.2014.03.005. View

ODonnell M, Teo K, Gao P, Anderson C, Sleight P, Dans A . Cognitive impairment and risk of cardiovascular events and mortality. Eur Heart J. 2012; 33(14):1777-86. DOI: 10.1093/eurheartj/ehs053. View

Beishon L, Harrison J, Harwood R, Robinson T, Gladman J, Conroy S . The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens. 2013; 28(5):283-7. DOI: 10.1038/jhh.2013.107. View

10.

Jacobs J, Stessman J, Ein-Mor E, Bursztyn M . Hypertension and 5-year mortality among 85-year-olds: the Jerusalem Longitudinal Study. J Am Med Dir Assoc. 2012; 13(8):759.e1-6. DOI: 10.1016/j.jamda.2012.05.005. View

11.

Claassen J, Zhang R . Cerebral autoregulation in Alzheimer's disease. J Cereb Blood Flow Metab. 2011; 31(7):1572-7. PMC: 3137479. DOI: 10.1038/jcbfm.2011.69. View

12.

Borjesson-Hanson A, Gustafson D, Skoog I . Five-year mortality in relation to dementia and cognitive function in 95-year-olds. Neurology. 2007; 69(22):2069-75. DOI: 10.1212/01.wnl.0000280464.59322.af. View

13.

Pradier C, Sakarovitch C, Le Duff F, Layese R, Metelkina A, Anthony S . The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database. PLoS One. 2014; 9(8):e103630. PMC: 4122367. DOI: 10.1371/journal.pone.0103630. View

14.

Jellinger K . Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegener Dis. 2010; 7(1-3):112-5. DOI: 10.1159/000285518. View

15.

Molander L, Lovheim H . Blood pressure change and antihypertensive treatment in old and very old people: evidence of age, sex and cohort effects. J Hum Hypertens. 2012; 27(3):197-203. DOI: 10.1038/jhh.2012.14. View

16.

Cacciatore F, Abete P, De Santis D, Longobardi G, Ferrara N, Rengo F . Mortality and blood pressure in elderly people with and without cognitive impairment. Gerontology. 2004; 51(1):53-61. DOI: 10.1159/000081436. View

17.

Nilsson S, Read S, Berg S, Johansson B, Melander A, Lindblad U . Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res. 2007; 19(1):41-7. DOI: 10.1007/BF03325209. View

18.

Post Hospers G, Smulders Y, Maier A, Deeg D, Muller M . Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med. 2014; 277(4):488-97. DOI: 10.1111/joim.12284. View

19.

Guo Z, Viitanen M, Winblad B . Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors. Am J Public Health. 1997; 87(4):623-8. PMC: 1380843. DOI: 10.2105/ajph.87.4.623. View

20.

Aarsland D, Perry R, Brown A, Larsen J, Ballard C . Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol. 2005; 58(5):773-6. DOI: 10.1002/ana.20635. View